On 18 May, 2016, Jiangsu Sanbao
Pharmaceutical Co., Ltd. (Sanbao Pharmaceutical) was reported to speed up the
construction of its 1,000 t/a amino acid project (including derivatives), into
which has been injected altogether USD23.23 million (RMB150 million).
![](http://www.cnchemicals.com/Webdata/WebResources/image/20160616/20160616091928_8470.jpg)
The new amino acid plant, with an area of 11.33 ha (170 mu), will be equipped with new
production and ancillary facilities. After it can produce at full capacity, the
total sales are projected to reach USD30.98 million (RMB200 million) and
profits and taxes to USD4.65 million (RMB30 million).
According to CCM's research, Sanbao Pharmaceutical was founded in Sept. 2014
and boasts a R&D center for quality control and technology upgrading. It
focuses on the R&D, production and sales of amino acids and derivatives,
like amino acids extracted from plants, amino acid chelates and amino acid
salts. Specifically:
-
Knockout products: L-leucine, L-tyrosine
and sodium L-aspartate
-
N-acetyl amino acid series:
N-acetyl-L-methionine, N-acetyl-DL-methionine and N-acetyl-L-tryptophan
-
Other refined amino acid series:
DL-methionine, threonine and L-methionine
Focus on high value-added amino acids
Zhao Jichun, a manager of Sanbao Pharmaceutical, disclosed, "We are the
innovator of these amino acids, and we are applying for national patents for
invention. So far, our products have been tested and recognized on the spot by
both national authorities and Germany clients."
According to the State Intellectual Property Office, in Sept. 2015, Sanbao
Pharmaceutical obtained a patent for technology named A Method of Extracting
L-leucine from Plant Proteins. This technology, with high yields of L-leucine,
does less harm to the environment by avoiding the use of regular precipitants.
Thus, it shows relatively high economic benefits.
L-leucine, one of the high value-added minor amino acids, is mainly used in
medical treatment, especially helpful in cases like providing nutrition for the
seriously ill and rescuing the patients in emergency. At present, the global
output of L-leucine is around 7,000 tonnes (China: around 2,100 tonnes), vs.
global demand at about 28,000 tonnes. China's market price of L-leucine reaches
USD0.03-0.05/g (RMB0.2-0.3/g).
![](http://www.cnchemicals.com/Webdata/WebResources/image/20160809/20160809170241_7436.bmp)
A producer with patent for invention on high value-added amino acids can be
more competitive in the market.
"Besides the good business climate, it is the outstanding quality of our
products that wins the recognition from national authorities and Germany
clients. From the design and construction of plant to the purchase of
production facilities and choice of production techniques, we always adhere to
the principle that quality comes first," said Zhao Jichun.
Sanbao Pharmaceutical targets at well-known enterprises and merchants at home
and abroad. So far, thanks to its strict control on quality, the company has
attracted many merchants to sign long-term supply agreements.
In this context, the company launched a new amino acid project in Jan. 2015.
Yet, no specific information has been offered on what amino acids it is planned
to produce. However, according to information on the company's business
license, the new project may also focus on the production of its knockout
products. At present, it speeds up the installation and adjustment of
production facilities in the new plant, trying to finish construction and start
pilot production by the end of May.
So far, construction of the new plant has been going on orderly and smoothly:
infrastructure, like roads and facilities for water delivery and power supply,
continues being put up. "We are trying our best to finish the project
earlier to take up larger sales in the market," said the head of this
project.
This article comes from Amino Acids China E-News 1605, CCM
![](http://www.cnchemicals.com/Webdata/WebResources/image/20160616/20160616091111_7521.jpg)
About CCM:
CCM is the leading market intelligence provider for China's
agriculture, chemicals, food & ingredients and life science markets.
Founded in 2001, CCM offers a range of data and content solutions, from price
and trade data to industry newsletters and customized market research reports.
Our clients include Monsanto, DuPont, Shell, Bayer, and Syngenta. CCM is a
brand of Kcomber Inc.
For more information about CCM, please
visit www.cnchemicals.com or get in touch with us
directly by emailing econtact@cnchemicals.com or calling
+86-20-37616606.
Tag: amino acid